VYNE Therapeutics Inc.
VYNE Therapeutics Inc. (VYNE) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 128 transactions totaling $15.9M, demonstrating a bullish sentiment with $5.2M in net insider flow. The most recent transaction on Dec 31, 2025 involved a transaction of 3,579 shares valued at $2.1K.
VYNE Insider Activity Summary
Who Is Buying VYNE Stock?
No significant insider buying has been recorded for VYNE in the recent period.
Who Is Selling VYNE Stock?
No significant insider selling has been recorded for VYNE in the recent period.
Is VYNE Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for VYNE is bullish with an Insider Alignment Score of 66/100 and a net flow of $5.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
VYNE Frequently Asked Questions
Understanding VYNE Insider Activity
Insider trading at VYNE Therapeutics Inc. (VYNE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading VYNE stock, having executed 128 transactions in the past 90 days. The most active insider is Life Sciences Master Fund Ltd Perceptive (Executive), who has made 2 transactions totaling $10.8M.
Related Tools
Track VYNE Therapeutics Inc. Insider Activity
Get notified when executives and directors at VYNE file new Form 4 transactions